Hormone Optimisation Programme

Bioidentical hormone optimisation programmes for men and women, addressing testosterone, oestrogen, progesterone, thyroid, and cortisol imbalances through physician-monitored replacement and restoration protocols.

Helix Privé's hormone optimisation programme is a cornerstone of its longevity medicine offering, addressing one of the most pervasive and overlooked drivers of accelerated ageing: hormonal decline. From the mid-thirties onward, key hormones including testosterone, oestrogen, progesterone, DHEA, and growth hormone begin to decline — a process that drives fatigue, cognitive fog, reduced muscle mass, weight gain, mood dysregulation, and diminished libido. Dr. Sumit Jain takes a precision approach to hormone medicine, beginning with a comprehensive baseline panel that measures free and total testosterone, oestradiol, progesterone, FSH, LH, DHEA-S, SHBG, IGF-1, thyroid panel (TSH, free T3, free T4, reverse T3), cortisol rhythm, and insulin. This diagnostic depth allows the clinical team to understand not just whether hormone levels are technically within 'normal' range, but whether they are optimal for that individual's age, symptoms, and health goals. For men, testosterone replacement therapy (TRT) is offered in a variety of delivery formats — subcutaneous injections, topical gels, or pellet implants — alongside supporting protocols to maintain testicular function and prevent oestrogen conversion. Men's programmes may also include HCG, anastrozole, and DHEA supplementation where indicated. For women, bioidentical hormone replacement therapy (BHRT) addresses perimenopause and menopause symptoms including hot flashes, brain fog, sleep disruption, and bone density loss. Oestradiol and progesterone are prescribed in physiological ratios, with continuous monitoring to ensure safety and efficacy. Testosterone therapy for women — addressing libido, energy, and cognitive function — is also offered. Thyroid and adrenal programmes are available for clients with subclinical hypothyroidism, adrenal fatigue, or HPA-axis dysregulation. All hormone programmes include quarterly blood monitoring and physician review appointments to adjust dosing in line with evolving lab results and clinical response.